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ABSTRACT
Background Subcutaneous injection of tumescent 
solution, which contains local anesthetic, adrenaline, 
and saline, before split-thickness skin graft harvesting, 
shows a significant hemostatic effect. This method can 
reduce the initial bleeding from the donor site. The aim 
of this study is to assess the benefits of controlling the 
bleeding from donor sites by tumescent injection. A 
randomized, controlled trial was performed to compare 
the wound healing of split-thickness skin graft donor 
sites treated with or without tumescent injection.
Methods This randomized, controlled trial examined 
donor site healing days as the main measure of outcome. 
postoperative pain, donor site ulceration, and scar qual-
ity were evaluated as secondary outcome measures. 
Patients planned for split-thickness skin graft harvest 
were randomly assigned to receive either pre-harvest 
subcutaneous injection of local anesthetic, adrenaline, 
and saline solution (tumescent solution) (Group 1) or 
post-harvest application of adrenaline solution-soaked 
gauze to the skin graft donor sites (Group 2). Donor sites 
were treated with calcium alginate dressings after graft 
harvesting. On the 10th postoperative day, the dressings 
were removed and donor site healing were measured. 
Follow-up evaluation of scar quality was performed 6 
months after surgery. Postoperative pain was evaluated 
on the 1st day after operating.
Results Forty-five patients (26 males; average age 
61.8 years) completed the late follow-up evaluation (6 
months postoperatively), with 26 patients in group 1 and 
19 in group 2. There were no significant differences be-
tween the two groups in any of the outcome measures.
Conclusion Tumescent technique provides sufficient 
hemostasis in split skin graft donor sites, especially 
the initial bleeding just after graft harvesting, without 
any negative effects. Larger series should be studied to 
evaluate the effect in donor site wound healing.
Key words donor site wounds; hemostasis; split-thick-
ness skin grafts; tumescent injection; wound healing
To control the bleeding from split-thickness skin graft 
donor sites, the use of several hemostatic agents has 
been reported.1, 2 Most of these agents are applied to 
the wound surface after graft harvesting. However, 
even with these methods, initial bleeding just after graft 
harvesting cannot be avoided. For hemostasis of split-
thickness skin graft donor sites, we prefer subcutane-
ous adrenaline administration with saline and local 
anesthetic before graft harvesting (i.e., the tumescent 
technique).3, 4 The tumescent technique describes the 
practice of injecting a dilute solution of adrenaline with 
local anesthetic subcutaneously until the tissue becomes 
swollen (tumescent). The hemostasis of this technique 
is due to both adrenaline-induced vasoconstriction and 
hydrostatic compression by the tumescent effect. It was 
originally used for liposuction. Since then, it has been 
most commonly used for dermatologic surgery for pain 
relief and hemostasis. Recently, the technique has been 
applied to a wider range of procedures, such as hair 
transplantation,5 mastectomy,6–8 burn excision,9and 
varicose vein surgery.10 The tumescent technique is 
also used for hemostasis of split-thickness skin graft 
donor sites.11 Compared to topical administration of 
adrenaline, the use of tumescent solution prior to graft 
harvest makes an apparent difference in the immediate 
bleeding just after graft harvesting (Fig. 1). By stopping 
this initial bleeding from the donor site, contamina-
tion of wound dressings can be minimized (Fig. 2). 
Contaminated wound dressings tend to stick to the 
wound, and firmly fixed wound dressings could damage 
the surface during dressing changes. Remaining clots 
on the wound surface could be a cause of infection. 
Avoiding these issues would thus help donor site wound 
healing.
The aim of this study is to evaluate the efficacy of 
hemostasis by tumescent technique in split-thickness 
skin graft donor site wound healing. To assess the 
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benefits of controlling the bleeding from donor sites, a 
randomized, controlled trial was performed to compare 
the wound healing of split-thickness skin graft donor 
sites treated with or without tumescent injection.
MATERIAL AND METHODS
Study design
This was a prospective, randomized controlled trial. 
Days required for donor site wound healing was exam-
ined as the main measure for outcome. Postoperative 
pain, donor site ulceration, and scar quality were evalu-
ated as the secondary outcome measures.
Patients selection criteria
For this study, patients admitted to Tottori University 
Hospital and Shimane Prefectural Central Hospital 
between April 2013 and March 2016 with skin defects 
and planned for split-thickness skin graft harvest from 
the thigh were recruited.
The study was approved by the Institutional 
Review Board at Tottori University Hospital (approval 
number 2399).
Patients who met the following selection criteria 
were included: no skin disease or skin trouble that 
could affect wound healing; informed consent could be 
obtained; age between 20 and 84 years; and donor site 
size ≥ 20 cm2. Individuals who refused to participate in 
the study and participants who were judged not suitable 
for the study were excluded. When the experiment or 
postoperative follow-up was unable to be continued 
due to interruptions such as the participant’s death or 
a hospital transfer, such cases were also excluded from 
the study.
Before the operative procedure, informed consent 
was obtained from the study participants using a 
document showing the details of the treatment and the 
research. After participants’ consent was obtained, 
registration numbers were given to each participant. 
They were then randomly assigned to receive either 
pre-harvest subcutaneous injection of local anesthetic, 
adrenaline, and saline solution (tumescent solution) 
(Group 1) or post-harvest application of adrenaline 
solution-soaked gauze to the skin graft donor sites as a 
hemostatic procedure (Group 2).
Operation procedure
The grafting procedure was performed under general 
anesthesia according to the standard procedure in our 
institution. In Group 1, tumescent solution (0.9% inject-
able saline with 0.05 mL adrenaline 1:1000, 50 mL 1% 
lidocaine in 1000 mL) was injected subcutaneously 
before skin graft harvesting. In Group 2, saline solution 
(0.9% injectable saline) was injected subcutaneously be-
fore harvesting, and epinephrine solution-soaked gauze 
(0.9% injectable saline with 10 mL adrenaline 1:1000 in 
1000 mL) was topically applied to the wound after graft 
harvesting. The skin graft was harvested with an elec-
tric dermatome (Zimmer Surgical, Inc., Dover, OH) at a 
thickness of 12/1000ths of an inch. After the graft was 
taken, a calcium alginate dressing (AlgoDERM, Smith 
& Nephew, London, UK) was applied to the donor sites. 
The donor sites were then dressed in sterile gauze and 
fixed with medical bandages (Fig. 3).
Evaluation methods
On the 10th postoperative day, the dressing was opened 
to check the wounds. Photographs of the donor site 
were then taken every day to assess donor site healing. 
Wounds were judged as healed when the remaining 
ulcer area was under 1 cm2. Evaluation of scar quality 
Fig. 1. Difference in bleeding from the split-thickness donor sites. 
The right side received tumescent injection before graft harvest-
ing, and the left side received only saline injection.
Fig. 2. Differences in wound dressings. Dressings on the donor 
site with tumescent solution (right side) have minimal contamina-
tion. Dressings on the donor site without tumescent injection tend 
to be firm and stuck to the wound surface.
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(hypertrophy and/or ulceration formation, wound 
photograph data) was performed at least 6 months after 
surgery. The evaluators were selected from among the 
nurses in the plastic surgery department. Postoperative 
pain was assessed subjectively on the 1st postoperative 
day, using a 10-grade linear scale (0 = little or no pain, 
10 = intolerable pain); the data were obtained from a 
nurse interview form. Data analysis was performed us-
ing statistical analysis software (Stat Flex ver. 6, Artech 
Co., Osaka, Japan). Mann-Whitney U test or Fisher’s 
exact test for paired samples was used to determine 
whether there were any differences between the two 
groups. P values of < 0.05 were considered significant.
RESULTS
Patients characteristics
A total of 49 patients (33 male and 16 females; average 
age 63.3 years) from Tottori University Hospital and 
Shimane Prefectural Central Hospital with various skin 
defects were included in the study. Of them, 45 patients 
(26 male and 19 females; average age 61.8 years) 
completed the late follow-up evaluation (6 months after 
operation). Four patients could not complete the follow-
up evaluation; 1 patient died during the follow-up pe-
riod, and 3 patients did not come to the outpatient clinic 
after being discharged or transferred (Fig. 4). Group 1 
consisted of 26 patients, and Group 2 consisted of 19 pa-
tients. There were no significant differences between the 
two groups in age, sex, wound size. The most frequent 
cause of skin defect was burns in both groups (Table 1).
Analysis of the outcome measures
Donor sites healed within an average of 14.8 days in 
group 1 and 20.4 days in group 2, with no significant 
difference between the two groups. Average postopera-
tive pain reported on day 1 was 3.46/10 in group 1 and 
2.84/10 in Group 2, with no significant difference.
In the late follow-up period, ulceration of the 
healed site occurred in 9 cases in both groups (Group 
1 34.6%, Group 2 47.4%). Hypertrophic scar forma-
tion was seen in one patient in Group 2. There was no 
significant difference between the two groups (Table 
Fig. 3. Operative procedure. Group 1 received tumescent solution injection subcutaneously before skin graft harvesting. Group 2 re-
ceived saline solution injection subcutaneously before harvesting, and adrenaline (epinephrine) solution-soaked gauze was applied after 
graft harvesting. Skin grafts were harvested with a Zimmer electric dermatome at a thickness of 12/1000th of an inch. Calcium alginate 
dressing was applied to the donor site 15minutes after graft harvesting in both groups.
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2). One infection occurred in Group 2. No cardiac 
arrhythmias or significant increases in heart rate were 
observed following the injection of adrenaline. No other 
side effects were reported.
DISCUSSION
This present study compared wound healing in two dif-
ferent hemostatic techniques: the tumescent technique 
and topical application of adrenaline solution. Both 
methods have sufficient hemostatic effect, but tumescent 
injection can control the initial bleeding just after graft 
harvesting. Compared to topical administration of 
adrenaline, the use of tumescent solution prior to graft 
harvest makes an apparent difference in the immedi-
ate bleeding just after graft harvesting. We expected 
improvement in donor site wound healing by controlling 
Fig. 4. Participant flow chart according to the CONSORT (Consolidated Standards for Reporting Trials) guidelines.12 The number of 
patients who completed the follow-up period is 26 in group 1 and 19 in group 2.
Table 1. Comparison between participants randomized to group 1 (tumescent injection to donor sites) or group 
2 (topical administration of adrenaline)
Group 1 (n = 26) Group 2 (n = 19) P-value
Age (y) 59.2 (20–84) 64.5 (38–84) 0.294
Sex (male: female) 18:8 13:6 1.000
Wound size (cm2) 139.1 (35–250) 101 (24–200) 0.692
Cause of skin defect (n) Burn 20 (77%) 
Trauma 2 (7%) 
Foot ulcer 1 (4%) 
Malignancy 1 (4%) 
Necrotizing fasciltis 1 (4%) 
Cronic pyoderma 1 (4%)
Burn 16 (84%) 
Foot ulcer 2 (11%) 
Necrotizing fasciltis 1 (5%)
y, years.
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this initial bleeding, but the results of this present study 
showed no significant difference in donor site wound 
healing or scar quality. Possible reasons of this result 
are the small sample size, and the use of hemostatic 
procedure for both groups.
There are several reports that suggest the effective-
ness of adrenaline injection before skin graft harvesting. 
Groenewold et al. performed a systematic review to 
assess the effectiveness of hemostatic agents for split-
thickness skin graft donor sites. They reported that 
adrenaline and fibrin sealant showed more effective 
hemostasis than other agents.2 Gacto et al. reported that 
the re-epithelialization of the split-thickness skin graft 
donor site was faster in a group treated with adrenaline 
before graft harvesting than in a group treated with 
saline.13 The group that received subcutaneous adrena-
line injection needed fewer dressing changes than 
the control group and thus required shorter time for 
epithelialization.
In the present study, there was neither delayed 
healing nor any negative effect on scar quality in those 
treated with subcutaneous injection of tumescent solu-
tion. It is known that moderate bleeding is a necessary 
process for wound healing.14 Platelets secrete several 
growth factors, such as vascular endothelial growth 
factor (VEGF), platelet-derived growth factor (PDGF), 
and transforming growth factor-β (TGF-β). These 
factors promote neovascularization, cell proliferation, 
and chemotaxis.15 Hemostasis by tumescent technique 
might impede these functions, and may therefore result 
in delayed wound healing of the donor sites. In response 
to this concern, Blome-Eberwein et al. examined the 
effects of adrenaline/saline/local anesthetic solution on 
donor site perfusion and wound healing.11 They showed 
that subcutaneously injected adrenaline/saline/local 
anesthetic solution did not affect donor site healing time 
or long-term scar quality. 
Due to the effect of local anesthetics in the tumes-
cent solution, postoperative pain relief was expected. 
However, there was no significant effect. As possible 
reasons for this result, the reaction time and the types of 
anesthetics may be considered. In addition, pain evalu-
ation limited to the skin graft donor site was difficult, 
because every case had other wounds that were larger 
than the skin graft donor sites.
As a supplemental effect of tumescent technique, 
subcutaneous infiltration of tumescent solution can 
facilitate dermatome contact by raising contoured areas. 
This procedure thus simplifies skin harvest from the 
abdomen or back and allows the surgeon to take thinner 
grafts.
There are several limitations in this study. First, 
the number of cases was too small. Required sample 
size was 70 cases in each group according to the sample 
size calculation program.16 It was not able to achieve the 
required sample size within the study duration. Small 
sample size possibly affected the result of the analysis. 
Second, both groups received hemostatic agents, and 
application of wound dressings with hemostatic effect. 
To investigate the advantage of the tumescent technique, 
we planned to nominate the non-hemostatic procedure 
group as the control. But the plan was rejected by the 
Institutional Review Board from an ethical perspective. 
Calcium alginate dressings contain a blood clotting fac-
tor; this selection of wound dressing made the difference 
insignificant between the two groups.
In conclusion, injecting tumescent solution before 
graft harvesting provides guaranteed hemostasis, 
including the initial bleeding just after graft harvesting, 
without any negative effects. This method can be used 
routinely for split-thickness skin graft harvesting. A 
larger population of patients should be studied to evalu-
ate the effect of tumescent technique in wound healing.
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